Brevan Howard Capital Management »

Adaptive Biotechnologies Cor shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0M 371k 16.26
2025-09-30 $246k 16k 14.96
2025-03-31 $447k 60k 7.43
2024-12-31 $150k 25k 6.00

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
First Tr Exchange Traded Sm Cap Buywrite (FTKI)
Pdd Holdings Sponsored Ads Call Option (PDD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Alphabet Cap Stk Cl A (GOOGL)
Bank of America Corporation Call Option (BAC)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores Call Option (WMT)
Select Sector Spdr Tr State Street Uti Call Option (XLU)

View all positions for Brevan Howard Capital Management

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Westfield Capital Management Company
Geode Capital Management
State Street Corporation
Invesco
Lord, Abbett & Co
Goldman Sachs Group
Driehaus Capital Management
Jennison Associates
Ameriprise Financial
Arrowstreet Capital, Limited Partnership
Fred Alger Management
Wellington Management Company

View all funds holding Adaptive Biotechnologies Cor